A citation-based method for searching scientific literature

Susana David, Vanessa Correia, Liliana Antunes, Ricardo Faria, José Ferrão, Paula Faustino, Baltazar Nunes, Fernando Maltez, João Lavinha, Helena Rebelo de Andrade. Immunogenetics 2018
Times Cited: 13







List of co-cited articles
85 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
462
100

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals.
Yong-Hong Zhang, Yan Zhao, Ning Li, Yan-Chun Peng, Eleni Giannoulatou, Rong-Hua Jin, Hui-Ping Yan, Hao Wu, Jin-Hua Liu, Ning Liu,[...]. Nat Commun 2013
165
84

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
814
84

IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.
Yang Pan, Peng Yang, Tao Dong, Yi Zhang, Weixian Shi, Xiaomin Peng, Shujuan Cui, Daitao Zhang, Guilan Lu, Yimeng Liu,[...]. Front Cell Infect Microbiol 2017
19
69

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
241
69

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
E Kaitlynn Allen, Adrienne G Randolph, Tushar Bhangale, Pranay Dogra, Maikke Ohlson, Christine M Oshansky, Anthony E Zamora, John P Shannon, David Finkelstein, Amy Dressen,[...]. Nat Med 2017
83
69

Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Adrienne G Randolph, Wai-Ki Yip, Emma Kaitlynn Allen, Carrie M Rosenberger, Anna A Agan, Stephanie A Ash, Yu Zhang, Tushar R Bhangale, David Finkelstein, Natalie Z Cvijanovich,[...]. J Infect Dis 2017
35
61

IFITM3 and susceptibility to respiratory viral infections in the community.
Tara C Mills, Anna Rautanen, Katherine S Elliott, Tom Parks, Vivek Naranbhai, Margareta M Ieven, Christopher C Butler, Paul Little, Theo Verheij, Chris S Garrard,[...]. J Infect Dis 2014
54
61

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
149
61

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
Shokouh Makvandi-Nejad, Henry Laurenson-Schafer, LiLi Wang, Dannielle Wellington, Yan Zhao, Boquan Jin, Ling Qin, Kerry Kite, Hooman K Moghadam, Chaojun Song,[...]. J Infect Dis 2018
24
53

IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
Nelson Lee, Bin Cao, Changwen Ke, Hongzhou Lu, Yunwen Hu, Claudia Ha Ting Tam, Ronald Ching Wan Ma, Dawei Guan, Zhaoqin Zhu, Hui Li,[...]. J Infect Dis 2017
28
53

IFITM3 and severe influenza virus infection. No evidence of genetic association.
M López-Rodríguez, E Herrera-Ramos, J Solé-Violán, J J Ruíz-Hernández, L Borderías, J P Horcajada, E Lerma-Chippirraz, O Rajas, M Briones, M C Pérez-González,[...]. Eur J Clin Microbiol Infect Dis 2016
26
53

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
164
53

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
199
53

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
114
53


Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
76
46


IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
203
46

IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis.
Y Xuan, L N Wang, W Li, H R Zi, Y Guo, W J Yan, X B Chen, P M Wei. Epidemiol Infect 2015
24
38

Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Zhongfang Wang, Anli Zhang, Yanmin Wan, Xinian Liu, Chao Qiu, Xiuhong Xi, Yanqin Ren, Jing Wang, Yuan Dong, Meijuan Bao,[...]. Proc Natl Acad Sci U S A 2014
183
38

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
352
38

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
105
38

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
133
38

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
69
38

Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
Tonia C Carter, Scott J Hebbring, Jixia Liu, Jonathan D Mosley, Christian M Shaffer, Lynn C Ivacic, Sarah Kopitzke, Elisha L Stefanski, Rob Strenn, Maria E Sundaram,[...]. J Med Virol 2018
7
57


Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.
Vânia Gaio, Baltazar Nunes, Pedro Pechirra, Patrícia Conde, Raquel Guiomar, Carlos Matias Dias, Marta Barreto. PLoS One 2016
12
33

Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
Xianxian Yang, Bin Tan, Xipeng Zhou, Jian Xue, Xian Zhang, Peng Wang, Chuang Shao, Yingli Li, Chaorui Li, Huiming Xia,[...]. PLoS One 2015
28
30

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
56
30

The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
Sumudu K Narayana, Karla J Helbig, Erin M McCartney, Nicholas S Eyre, Rowena A Bull, Auda Eltahla, Andrew R Lloyd, Michael R Beard. J Biol Chem 2015
66
30

Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome.
Zheng Xu-Yang, Bian Pei-Yu, Ye Chuan-Tao, Ye Wei, Ma Hong-Wei, Tang Kang, Zhang Chun-Mei, Lei Ying-Feng, Wei Xin, Wang Ping-Zhong,[...]. Front Immunol 2017
24
30

Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
Krishna C Suddala, Christine C Lee, Paul Meraner, Mariana Marin, Ruben M Markosyan, Tanay M Desai, Fredric S Cohen, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2019
28
30


Antiviral Protection by IFITM3 In Vivo.
Ashley Zani, Jacob S Yount. Curr Clin Microbiol Rep 2018
25
30

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.
Xuesen Zhao, Jiarui Li, Cheryl A Winkler, Ping An, Ju-Tao Guo. Front Microbiol 2019
42
30

Human Genetic Determinants of Viral Diseases.
Adam D Kenney, James A Dowdle, Leonia Bozzacco, Temet M McMichael, Corine St Gelais, Amanda R Panfil, Yan Sun, Larry S Schlesinger, Matthew Z Anderson, Patrick L Green,[...]. Annu Rev Genet 2017
49
23

Association of IFITM3 rs12252 polymorphisms, BMI, diabetes, and hypercholesterolemia with mild flu in an Iranian population.
Parvaneh Mehrbod, Sana Eybpoosh, Fatemeh Fotouhi, Hadiseh Shokouhi Targhi, Vahideh Mazaheri, Behrokh Farahmand. Virol J 2017
4
75

The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Noelle-Angelique M Molinari, Ismael R Ortega-Sanchez, Mark L Messonnier, William W Thompson, Pascale M Wortley, Eric Weintraub, Carolyn B Bridges. Vaccine 2007
23

IFITM3 polymorphism rs12252-C restricts influenza A viruses.
David Evan Joseph Williams, Wan-Lin Wu, Christopher Robert Grotefend, Vladimir Radic, Changik Chung, Young-Hwa Chung, Michael Farzan, I-Chueh Huang. PLoS One 2014
33
23

Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3.
Jacob S Yount, Bruno Moltedo, Yu-Ying Yang, Guillaume Charron, Thomas M Moran, Carolina B López, Howard C Hang. Nat Chem Biol 2010
238
23

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.
Nicholas M Chesarino, Temet M McMichael, Jacob S Yount. Future Microbiol 2014
41
23

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
109
23

The IFITMs Inhibit Zika Virus Replication.
George Savidis, Jill M Perreira, Jocelyn M Portmann, Paul Meraner, Zhiru Guo, Sharone Green, Abraham L Brass. Cell Rep 2016
126
23

Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming.
Giuseppe Infusini, Jeffrey M Smith, He Yuan, Angela Pizzolla, Wy Ching Ng, Sarah L Londrigan, Ashraful Haque, Patrick C Reading, Jose A Villadangos, Linda M Wakim. PLoS One 2015
20
23

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
209
23


IFITM proteins-cellular inhibitors of viral entry.
Se Smith, S Weston, P Kellam, M Marsh. Curr Opin Virol 2014
74
23

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
23

The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Matthew J Gorman, Subhajit Poddar, Michael Farzan, Michael S Diamond. J Virol 2016
55
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.